First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile
The first-in-human trial for tebentafusp findings are in, and they show promise for managing a patients side effects to it.
GPRCD CAR T Shows Safety, Efficacy in Pretreated R/R Multiple Myeloma
The Reality of VTE: How to Best Address in Cancer Care
AI Decision Support Tools Serve as Copilots in Cancer Care
Toxicity Monitoring, Management Crucial for Tarlatamab in ES-SCLC